Grifols SA Ownership

GRFS Stock  USD 9.94  0.11  1.09%   
Grifols SA ADR has a total of 258.22 Million outstanding shares. Over half of Grifols SA's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2010-09-30
Previous Quarter
679.6 M
Current Value
680.4 M
Avarage Shares Outstanding
665.1 M
Quarterly Volatility
60.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grifols SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Grifols Stock Ownership Analysis

About 59.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.99. Some equities with similar Price to Book (P/B) outperform the market in the long run. Grifols SA ADR has Price/Earnings To Growth (PEG) ratio of 0.23. The entity last dividend was issued on the 3rd of June 2021. The firm had 2:1 split on the 4th of January 2016. Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols SA operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 27584 people. To learn more about Grifols SA ADR call Jose Buenache at 34 935 712 200 or check out https://www.grifols.com.
Besides selling stocks to institutional investors, Grifols SA also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Grifols SA's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Grifols SA's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Grifols SA Quarterly Liabilities And Stockholders Equity

21.41 Billion

Grifols Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Grifols SA is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Grifols SA ADR backward and forwards among themselves. Grifols SA's institutional investor refers to the entity that pools money to purchase Grifols SA's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2025-03-31
2.5 M
New York State Common Retirement Fund2025-03-31
2.5 M
Pictet Asset Manangement Sa2025-03-31
2.1 M
Sei Investments Co2025-03-31
2.1 M
Bank Of America Corp2025-03-31
M
Norges Bank2024-12-31
1.9 M
Ubs Group Ag2025-03-31
1.9 M
Flat Footed Llc2025-03-31
1.8 M
Blackrock Inc2025-03-31
1.7 M
Brandes Investment Partners & Co2025-03-31
25.7 M
Capital World Investors2025-03-31
21.5 M
Note, although Grifols SA's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Grifols SA Outstanding Bonds

Grifols SA issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Grifols SA ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Grifols bonds can be classified according to their maturity, which is the date when Grifols SA ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Grifols SA Corporate Filings

6K
12th of June 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
9th of April 2025
Other Reports
ViewVerify
14th of February 2025
Other Reports
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Grifols Stock Analysis

When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.